A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours
Robbrecht, Debbie G J, Lopez, Juanita, Calvo, Emiliano, He, Xiaomin, Hiroshi, Hirai, Soni, Nital, Cook, Natalie, Dowlati, Afshin, Fasolo, Angelica, Moreno, Victor, Eskens, Ferry A L M, de Bono, Johann S
Published in British journal of cancer (19.01.2021)
Published in British journal of cancer (19.01.2021)
Get full text
Journal Article
A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer
Yamamoto, Nobuyuki, Hayashi, Hidetoshi, Planchard, David, Morán, Teresa, Gregorc, Vanesa, Dowell, Jonathan, Sakai, Hiroshi, Yoh, Kiyotaka, Nishio, Makoto, Cortot, Alexis B., Benhadji, Karim A., Soni, Nital, Huang, Jinhong, Makris, Lukas, Cedres, Susana
Published in Investigational new drugs (01.10.2020)
Published in Investigational new drugs (01.10.2020)
Get full text
Journal Article
First-in-human phase I and pharmacological study of TAS-119, a selective Aurora A (AurA) kinase inhibitor, in patients (pts) with advanced solid tumors
Robbrecht, Debbie, Eskens, Ferry, Calvo, Emiliano, He, Xiaomin, Hirai, Hiroshi, Soni, Nital, Cook, Natalie, Dowlati, Afshin, Fasolo, Angelica, Moreno, Victor, De Bono, Johann S.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Phase I study of the Aurora A kinase (AurA) inhibitor TAS-119 with paclitaxel (P) in advanced solid tumors
Cardin, Dana Backlund, Park, Haeseong, Diamond, Jennifer Robinson, Drilon, Alexander E., VerMeulen, Wendy L., He, Xiaomin, Hirai, Hiroshi, Soni, Nital, Berlin, Jordan
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
FOENIX-CCA2: A phase II, open-label, multicenter study of futibatinib in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 gene fusions or other rearrangements
Goyal, Lipika, Meric-Bernstam, Funda, Hollebecque, Antoine, Valle, Juan W., Morizane, Chigusa, Karasic, Thomas Benjamin, Abrams, Thomas Adam, Furuse, Junji, He, Yaohua, Soni, Nital, Benhadji, Karim A., Bridgewater, John A.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Abstract CT010: Primary results of phase 2 FOENIX-CCA2: The irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
Goyal, Lipika, Meric-Bernstam, Funda, Hollebecque, Antoine, Morizane, Chigusa, Valle, Juan W., Karasic, Thomas B., Abrams, Thomas A., Kelley, Robin Kate, Cassier, Philippe, Furuse, Junji, Klümpen, Heinz-Josef, Chang, Heung-Moon, Chen, Li-Tzong, Komatsu, Yoshito, Masuda, Kunihiro, Ahn, Daniel, He, Yaohua, Soni, Nital, Benhadji, Karim A., Bridgewater, John A.
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Baseline cfDNA characteristics and evolution of cfDNA profile during treatment with selective FGFR inhibitor TAS-120
Moss, Tyler J., Rodon Ahnert, Jordi, Oakley, Holly D., Kahle, Michael, Karp, Daniel D., Pant, Shubham, Jacob, Jeena, Raymond, Victoria M., Lanman, Richard B., Kwong, Lawrence, Routbort, Mark, Soni, Nital, Huang, Jerry, Javle, Milind M., Meric-Bernstam, Funda
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article